Skip to main content
Trending
Jurisdictional limitsDrug safetyModel compressionStrait of hormuzPlanetary defenseAi tutoringClinical trialsFurniture safetyBattery chemistryBankruptcy mechanicsFootball financeStarch chemistryVehicle recallsWatershed restorationMultifamily distressEnterprise aiInformation theoryWi-fi 8 hardwareMarket strategyProduction economicsMetabolic scienceSpace-based sigintAviation safetyData structuresZaporizhzhia plantAutomotive regulationReit taxationClimate forcingSchool nutritionBiodiversity loss

Preventive Wellness

All HealthNutrition & DietSupplementsMental HealthSleepLongevityMedicineMedications & TreatmentsConditions & DiseasesHormones & EndocrinologySkincareDental HealthFamily HealthChildren's HealthMen's HealthWomen's HealthAging & GeroscienceBiohackingAlternative MedicinePublic HealthMedical ResearchPreventive WellnessHealthy Habits
Explainer

Landmark Study Overturns Decades of Dogma: Lung Transplant Achieves 100% One-Year Survival in Select Stage IV Lung Cancer Patients

4 sources · 56d ago

Explainer

First New Class of Schizophrenia Drug in Decades Targets Muscarinic Receptors, Halving Symptoms

4 sources · 57d ago

Explainer

FDA Approves First-in-Class Oral Non-Opioid Drug for Acute Pain, Offering Alternative to Addictive Narcotics

8 sources · 62d ago

More in Preventive Wellness

ExplainerACA Subsidies

What the Expiration of Enhanced ACA Subsidies Means for Health Coverage in 2026

Health Policy Researchers 40%Federal Administrators 35%Healthcare Providers 25%

3 sources · 62d ago

ExplainerWomen's Health

How a New Androgen 'Fingerprint' is Making Non-Surgical Endometriosis Diagnosis a Reality

Clinical Researchers 40%Patient Advocates 35%Public Health Officials 25%

5 sources · 62d ago

ExplainerPreventive Cardiology

The Evidence Pack: How Repatha is Rewriting the Rules of Primary Heart Disease Prevention

Preventive Cardiology Consensus 45%Health Economics & Payers 35%Patient Advocacy 20%

4 sources · 62d ago

ExplainerRespiratory Health

A Single Injection Is Replacing Steroids for Severe Asthma and COPD Attacks

Respiratory Researchers 39%Patient Advocacy Groups 39%Clinical Practitioners 22%

5 sources · 63d ago

ExplainerMotor Neurone Disease

How a New Drug Targeting the C5aR2 Receptor Could Turn Motor Neurone Disease Into a Chronic Condition

Structural Biologists 35%Patient Advocacy Groups 35%Clinical Neurologists 30%

2 sources · 63d ago

ExplainerPsychiatric Care

New Zealand Passes Landmark Mental Health Law, Ending Youth Seclusion and Overhauling Compulsory Care

Human Rights Advocates 40%Clinical Psychiatrists 35%Health Policymakers 25%

5 sources · 64d ago

ExplainerUlcerative Colitis

Landmark Trial Finds Simple Appendectomy Significantly Reduces Relapse in Ulcerative Colitis

Medical Researchers 40%Gastroenterologists & Surgeons 35%Patient Advocates & Editorial Synthesis 25%

6 sources · 65d ago

ExplainerIgA Nephropathy

How VOYXACT's APRIL Inhibition is Stabilizing Kidney Function in IgA Nephropathy

Clinical Researchers 40%Regulatory & Medical Consensus 35%Biopharma Developers 25%

3 sources · 66d ago

ExplainerAntibiotic Discovery

Landmark Study Finds Bacterial 'Megacluster' Producing Four Synergistic Antibiotics to Combat Drug Resistance

Evolutionary Microbiologists 35%Drug Discovery Researchers 35%Public Health Officials 30%

5 sources · 68d ago

ExplainerTreg Therapy

FDA Approves First-in-Class Regulatory T-Cell Therapy to Prevent Life-Threatening Graft-Versus-Host Disease

Transplant Oncologists 40%Cellular Engineering Researchers 35%Patient Advocacy Groups 25%

4 sources · 69d ago

ExplainerLipoprotein(a)

Landmark Phase 3 Trial: RNA-Targeted Drug Pelacarsen Significantly Reduces Heart Attacks by Neutralizing Untreatable Lp(a)

Preventive Cardiologists 40%Health Economists and Payers 30%Genetic Medicine Researchers 30%

5 sources · 69d ago

Blindspot

Important stories the mainstream barely covered

High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.

All blindspots →
news politics

House Passes Bill to Make Daylight Saving Time Permanent, Sending Measure to Senate

The U.S. House of Representatives voted 308-117 to pass the Sunshine Protection Act, advancing a bipartisan effort to end the twice-yearly clock changes. The legislation, backed by President Trump, now heads to the Senate where its future remains uncertain.

Permanent DST Advocates 45%Standard Time Proponents 35%Status Quo Defenders 20%

Explore more topics

News & PoliticsWorldBusinessFinanceTechnologyArtificial IntelligenceScienceEnergy